Showing posts with label medical marijuana study. Show all posts
Showing posts with label medical marijuana study. Show all posts

Friday, 23 August 2013

Sustain Group Forms For Medical Cannabis

An original sustain group has produced for medical cannabis patients.

The Corvallis Cannabis Support Group had its initial gathering last week, with five people in presence. Organizer Ed Glick is eager the journal meetings will cultivate as word gets out.

"I think the need has been about for a long time as of the disjointed services and require of services that endure to help marijuana patients," Glick said.

Glick, an ex-nurse and longtime supporter for medical marijuana, said the reason of the group is to help people conclude whether marijuana could be useful for their medical circumstances and offer a sympathetic environment for conversation of difficulties encountered in working with doctors.

Even though the Oregon Medical Marijuana Program has issued almost 56,000 cards to endorsed patients, Glick said, precise in order about the herb's therapeutic benefits can still be hard to come by - even from physicians.

"There's no reason for these thousands of patients to be unobserved by the medical institution," Glick said.

Glick emphasized that no cannabis use is permitted at the meetings.

"This is not a place for people to come and smoke pot," Glick said. "I'm hoping this hold group would be anywhere somebody's grandmother would be comfortable to come in and get answers."

The Corvallis Cannabis Support Group meets at 6 p.m. on the second Wednesday of each month in the offices of CAN! Research, Education and Consulting, 551 S.W. Fourth St. The next meeting will be Sept. 11.

For More Info: Medical Marijuana Updates

Wednesday, 2 January 2013

Medical Marijuana Study


Among the rows of plants growing at a government-approved medical marijuana farm in the Galilee hills in northern Israel, one strain is said to have the strongest psychoactive effect of any cannabis in the world. Another, rich in anti-inflammatory properties, will not get you high at all.

Marijuana is illegal in Israel, but farms like this one, at a secret location near the city of Safed, are at the cutting edge of the debate on the legality, benefits and risks of medicinal cannabis. Its staff members wear white lab coats, its growing facilities are fitted with state-of-the-art equipment for controlling light and humidity, and its grounds are protected by security cameras and guards.

In the United States, medical marijuana programs exist in 18 states but remain illegal under federal law. In Israel, the law defines marijuana as an illegal and dangerous drug, and there is still no legislation regulating its use for medicinal purposes.

Yet Israel's Ministry of Health issues special licenses that allow thousands of patients to receive medical marijuana, and some government officials are now promoting the country's advances in the field as an example of its pioneering and innovation.

Israelis have been at the vanguard of research into the medicinal properties of cannabis for decades.

Israeli researchers say cannabis can be beneficial for a variety of illnesses and conditions, from helping cancer patients relieve pain and ease loss of appetite to improving the quality of life for people with post-traumatic stress disorder and neuropsychological conditions. The natural ingredients in the plant, they say, can help with digestive function, infections and recovery after a heart attack.

The marijuana harvest, from plants that can grow over six feet tall, is processed into bags of flowers and ready-rolled cigarettes. There are also cannabis-laced cakes, cookies, candy, gum, honey, ointments and oil drops. The strain known as Eran Almog, which has the highest concentration of THC, is recommended for severe pain. Avidekel, a strain rich in CBD and with hardly any psychoactive ingredient, allows patients to benefit from the drug while being able to drive and to function at work.

Working with Hebrew University researchers, the farm has also developed a version in capsule form, which would make exporting the drug more practical, should the law allow it.

Professor Mechoulam, now 82, said in an interview that he had been urging producers over the years to grow cannabis with less THC and more CBD, something in which nonmedical marijuana growers had little interest. He said what Tikkun Olam had done was not great science but "a very practical development."

In Israel, he said, research in the field is "definitely a work in progress," and he cautioned, "Science is not a 100-meters Olympic race; it is not who is first on the line that is important."

The real advances, he said, are being made not on farms but in laboratories around the world, including in the United States and Europe. The professor, who collaborates with many teams abroad, said that chances were that in the next few years well-defined mixtures of the compounds, refined into something more like a medical drug, would replace today's medicinal marijuana.

To get quality medical cannabis products, visit: San Francisco medical marijuana dispensary.